
J&J launches IVL device in Europe; Medtronic looks at pacing for more patients
J&J’s Shockwave Javelin intravascular lithotripsy catheter treats people with peripheral artery disease.

J&J’s Shockwave Javelin intravascular lithotripsy catheter treats people with peripheral artery disease.

This manufacturing site in Richmond, Virginia, is the first of four projects that Eli Lilly plans to reveal this year as part of a $27 billion U.S. investment announced earlier this year.

BETHLEHEM, Pa., Sept. 15, 2025 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Tromethamine Injection in the EXCEL® IV Container 500 mL in the U.S. market. This addition enhances the company’s ability to serve the diverse needs of providers and their patients.

Johnson & Johnson MedTech‘s Shockwave Medical announced today that it launched its Javelin peripheral IVL catheter in Europe.

SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ — Shenzhen Sunsred Technology Co., Ltd. is shaking things up in the wellness tech world with its latest lineup of red light therapy devices.

The current step represents a major proof of concept in humans for TruLeaf’s innovative technology aimed at transcatheter replacement of the mitral and tricuspid valves

MASON, Ohio, Sept. 12, 2025 /PRNewswire/ — Haag-Streit USA, a leading manufacturer and distributor of ophthalmic diagnostic devices, surgical microscopes, and virtual reality-based medical simulators, is proud to announce the launch of two new innovations: the Elara 900 and the Refractor 900. Both products will make their international debut at ESCRS 2025 in Copenhagen and their US debut at the American Academy of Ophthalmology (AAO) annual meeting in October.

Teleflex (NYSE:TFX) announced today that it enrolled the first patient in its DUBSTENT DIABETES trial.

Mendaera today announced the world’s first procedures performed with its Focalist handheld robotic surgery system.

An Abbott (NYSE: ABT)+
official announced on social media that doctors completed the first commercial implant of Tendyne in the U.S.